A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors

Clinical trial NCT05615974 · RECRUITING

Trial details

NCT number: NCT05615974
Sponsor: LaNova Medicines Limited
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Tumors

Start date: 2023-01-11
Primary completion: 2027-01-11
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.